What is Immunome's current ratio?

Immunome (IMNM) reported current ratio of 21.7× in Q1 2026.

How has Immunome's current ratio changed year-over-year?

Immunome's current ratio increased by 106.6% year-over-year, from 10.5× to 21.7×.

What is the long-term trend for Immunome's current ratio?

Over 5 years (2020 to 2025), Immunome's current ratio has grown at a 0.8% compound annual growth rate (CAGR), from 14.1× to 14.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Immunome IMNM Current ratio

Current ratio at other companies

PfizerPFE

1.2×0.0×

Arcus BiosciencesRCUS

4×-1.3×

Nuvation BioNUVB

7.4×-1.6×

SELLAS Life Sciences Group, Inc.SLS

17.2×+12.6×

IDEAYA Biosciences, Inc.IDYA

10.7×-3.2×

ImmunityBio, Inc.IBRX

6.7×+4.4×

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Where this comes from

Calculated from Immunome’s reported figures.

total current assets/total current liabilities=21.7×

Based on the most recent quarter.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's current ratio?: Immunome (IMNM) reported current ratio of 21.7× in Q1 2026.
How has Immunome's current ratio changed year-over-year?: Immunome's current ratio increased by 106.6% year-over-year, from 10.5× to 21.7×.
What is the long-term trend for Immunome's current ratio?: Over 5 years (2020 to 2025), Immunome's current ratio has grown at a 0.8% compound annual growth rate (CAGR), from 14.1× to 14.7×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.